↓ Skip to main content

Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, October 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
26 Mendeley